Istari Oncology

OverviewSuggest Edit

Istari Oncology is a biotechnology company focused on immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a variety of tumors. It develops PVSRIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates (ADCs) comprising antibodies or antibody fragments to a variety of oncology targets.
TypePrivate
Founded2016
HQDurham, NC, US
Websiteistarioncology.com

Latest Updates

Employees (est.) (Jun 2022)28(-20%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Istari Oncology

Sean P. Nolan

Sean P. Nolan

Chairman of the Board
Garrett Nichols

Garrett Nichols

Chief Medical Officer
Jamie Iudica

Jamie Iudica

Chief Manufacturing Officer
Raymond Cheong

Raymond Cheong

Director
Robert R. Bonczek

Robert R. Bonczek

Director
Matthew R. Stober

Matthew R. Stober

President, Chief Executive Officer, Director
Show more

Istari Oncology Office Locations

Istari Oncology has offices in Durham, Morrisville and Chapel Hill
Durham, NC, US (HQ)
6 Davis Dr
Morrisville, NC, US
430 Davis Dr #560
Show all (3)

Istari Oncology Financials and Metrics

Summary Metrics

Founding Date

2016

Istari Oncology total Funding

$5.1 m

Istari Oncology latest funding size

$1.1 m

Time since last funding

5 years ago
Istari Oncology's latest funding round in May 2017 was reported to be $1.1 m. In total, Istari Oncology has raised $5.1 m
Show all financial metrics

Istari Oncology Cybersecurity Score

Cybersecurity ratingPremium dataset

A

97/100

SecurityScorecard logo

Istari Oncology Online and Social Media Presence

Embed Graph

Istari Oncology News and Updates

Istari Oncology Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its Viral Immunotherapy PVSRIPO

College Station, TX and Durham, NC, Oct. 26, 2021 (GLOBE NEWSWIRE) -- FUJIFILM Diosynth Biotechnologies (FDB) and Istari Oncology today announced that they have entered into an agreement for the manufacturing of Istari Oncology’s viral immunotherapy, PVSRIPO, currently being investigated for the t…

Istari Oncology Frequently Asked Questions

  • When was Istari Oncology founded?

    Istari Oncology was founded in 2016.

  • Who are Istari Oncology key executives?

    Istari Oncology's key executives are Sean P. Nolan, Garrett Nichols and Jamie Iudica.

  • How many employees does Istari Oncology have?

    Istari Oncology has 24 employees.

  • Who are Istari Oncology competitors?

    Competitors of Istari Oncology include Jiangsu Hansoh Pharmaceutical Group, Kyowa Kirin and Ethypharm.

  • Where is Istari Oncology headquarters?

    Istari Oncology headquarters is located at 6 Davis Dr, Durham.

  • Where are Istari Oncology offices?

    Istari Oncology has offices in Durham, Morrisville and Chapel Hill.

  • How many offices does Istari Oncology have?

    Istari Oncology has 3 offices.